Phenazepam

DB19164InvestigationalSmall molecule

Phenazepam is under investigation in clinical trial NCT03017430 (Pregabalin for Opiate Withdrawal Syndrome).

Chemical structure of Phenazepam
Formula / weight
C15H10BrClN2O · 349.61 g/mol (avg)
Also known as
2h-1,4-benzodiazepin-2-one, 1,3-dihydro-7-bromo-5-(2-chlorophenyl)- · 2h-1,4-benzodiazepin-2-one, 7-bromo-5-(2-chlorophenyl)-1,3-dihydro- · 7-bromo-5-(2-chlorophenyl)-1,3-dihydro-2h-1,4-benzodiazepin-2-one · Fenazepam · Phenzitat
Code names
BD-98

Resolves to

Compound
UNII3DSB43090ZCAS51753-57-2ChEMBLCHEMBL1709464
Clinical / RWD
PharmGKBPA166180939
Structure
InChIKeyCGMJQQJSWIRRRL-UHFFFAOYSA-NSMILESClC1=CC=CC=C1C1=NCC(=O)NC2=CC=C(Br)C=C12
Targets
P22303ACHE

What you can answer from here — as of July 27, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
1Clinical trialPhase, status and sponsor resolved per trial
Sign in
4+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Phenazepam, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In